Should sFLC tests be used as a screen for monoclonal gammopathies instead of SPE?
No. SPE detects intact immunoglobulin monoclonal proteins and some FLC monoclonal proteins. In contrast, sFLC assays detect FLC monoclonal gammopathies, either alone, or in association with intact monoclonal immunoglobulins. Approximately 95% of patients with intact monoclonal immunoglobulins have abnormal sFLCs, but not all, particularly those patients with low concentration MGUS.